Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Development of TLR9 agonists for cancer therapy.
Established Outpatient Care and Follow-Up After Acute Psychiatric Service Use Among Youths and Young Adults.
Rothstein, Robert
Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of TLR9 agonists for cancer therapy.
Krieg AM. Development of TLR9 agonists for cancer therapy. J Clin Invest. 2007 May; 117(5):1184-94.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Drug Design
Humans
Neoplasms
Toll-Like Receptor 9
authors with profiles
Arthur M Krieg MD